Precision Risk Stratification in Kidney Transplant Patients - EU-TRAIN

Plain-language summary

This study examines more precise risk stratification after transplantation in kidney transplant patients. Eligible participants are 18 or older at the time of transplantation and receiving a living or deceased donor kidney. It was conducted as an observational study without a formal phase and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Completed

Sponsor

Assistance Publique - Hôpitaux de Paris

Intervention

kidney transplantation

Start date

11/27/2018

Estimated completion

10/28/2021

Countries

France, Germany, Spain, Switzerland

Related genes

Locations

• Le Kremlin-Bicêtre, France
• Nantes, France
• Paris, France
• Paris, France
• Mitte, Germany
• Berlin, Germany
• Barcelona, Spain
• Barcelona, Spain
• Geneva, Switzerland

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Men and women, Age ≥ 18 years old at the time of transplantation.
* Patients receiving a living or deceased donor kidney allograft.
* Patients who signed the informed consent form and willing to comply with study procedures.
* Female patients of child-bearing potential must have a negative pregnancy test (serum beta-hCG) and must be practicing an effective, reliable and medically approved contraceptive regimen

Exclusion Criteria:

* History of multi-organ transplant (interference with rejection natural history).
* Participant is unable or unwilling to comply with study procedures (including foreign language speakers who are not assisted by a native language speaker).
* Vulnerable participants (minors, protected adults, legally detained)